Literature DB >> 3009977

On the mechanism of opioid-oestradiol interactions.

M Vértes, Z Pámer, J Garai.   

Abstract

Characteristics of opioid binding and possible relationships between oestradiol and opioid binding sites were studied in rat oestrogen sensitive tissues(uterus, preoptic area-anterior hypothalamus, median eminence-basal hypothalamus). Naloxone (Nal) and oestradiol (Oe) bindings were assessed by in vitro saturation analyses. In 800 g supernatants of both uterine and hypothalamic tissues homogenates high affinity (Kd: 2-4 X 10(-9) M) and low capacity [3H]Nal binding sites were found. These binding sites were sedimented from 800 g supernatant by further centrifugation at 10(5) g for 1 h. In competition studies [3H]Nal binding was completely prevented by morphine, while met-enkephalin and leu-enkephalin caused only a partial inhibition. [3H]Nal binding was increased by ovariectomy and decreased by Oe treatment (10 micrograms/100 g b.wt) in both tissues. The cytoplasmic [3H]Oe binding in the studied tissues seems to be affected by the naloxone binding system. After in vitro saturation of naloxone binding sites by naloxone the [3H]Oe binding to low affinity sites (type II) in hypothalamus as well as in uterus has been increased by 8- and 2-fold, respectively. These results indicate the presence of specific [3H]Nal binding in rat uterus with similar properties to those found in the hypothalamus. Furthermore an interaction between opioid and oestradiol receptor systems could be also suggested.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009977     DOI: 10.1016/0022-4731(86)90056-7

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  3 in total

1.  Epidermal growth factor influenced by opioid peptides in immature rat uterus.

Authors:  Z Vértes; A Sándor; K A Kovács; A Oszter; J L Környei; S Kovács; M Vértes
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

2.  Immunoreactive opioid peptides in human breast cancer.

Authors:  L Scopsi; E Balslev; N Brünner; H S Poulsen; J Andersen; F Rank; L I Larsson
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

3.  Developmental changes in the inhibition of cultured rat uterine cell proliferation by opioid peptides.

Authors:  J L Környei; Z Vértes; K A Kovács; P M Göcze; M Vértes
Journal:  Cell Prolif       Date:  2003-06       Impact factor: 6.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.